Eli Lilly and Company

Overview & Background

The Idea

Eli Lilly was founded in 1876 by Colonel Eli Lilly, a Civil War veteran and pharmacist. The company's original idea was to create high-quality, affordable medicines that would help people live healthier lives.

Mission Statement

Eli Lilly's mission statement is to "create medicines that make life better." The company is committed to developing innovative medicines that treat a wide range of diseases, including cancer, diabetes, and Alzheimer's disease.

Eli Lilly is a global company with operations in over 125 countries. The company's headquarters are located in Indianapolis, Indiana.

In addition to its pharmaceutical business, Eli Lilly also has a philanthropic arm called the Lilly Endowment. The endowment supports a variety of charitable causes, including education, healthcare, and the arts.

Segments

Eli Lilly operates in three segments:

• Human Healthcare: This segment develops and markets medicines for a variety of diseases, including cancer, diabetes, and autoimmune disorders.
• Animal Health: This segment develops and markets medicines for livestock and companion animals.
• Biosimilars and Insulin: This segment develops and markets biosimilars, which are copies of biologic drugs, and insulin, a hormone that helps regulate blood sugar levels.

Projects

Eli Lilly is involved with a highly diversified product range in pharmaceuticals, offering solutions for various medical conditions and collaborating with a large number of companies as summarised below. Details are in the following section.

Overview of all products offered by Eli Lilly

Diabetes Medications

• Basaglar
• Humalog U-100, U-200
• Humalog Mix 75/25, Mix 50/50
• Insulin lispro, lispro protamine, lispro mix 75/25
• Humulin
• Humulin 70/30, N, R, U-500
• Jardiance, Trajenta, Trulicity for type 2 diabetes.

Cancer Treatments

• Alimta for non-small cell lung cancer (NSCLC) and malignant pleural mesothelioma.
• Cyramza for various cancer types including metastatic gastric cancer, NSCLC, and hepatocellular carcinoma.
• Erbitux for colorectal cancers and head and neck cancers.
• Retevmo for metastatic NSCLC, medullary thyroid cancer, and thyroid cancer.
• Tyvyt for classic Hodgkin's lymph and non-squamous NSCLC.
• Verzenio for metastatic breast cancer and early breast cancer.

Other Medical Conditions (Rheumatological, Dermatological, Psychiatric & Urologic)

• Olumiant for rheumatoid arthritis.
• Taltz for plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, and axial spondylarthritis.
• Cymbalta for depressive disorder, anxiety, fibromyalgia, and chronic pain.
• Emgality for migraine prevention and cluster headache.
• Zyprexa for schizophrenia, bipolar I disorder, and bipolar maintenance.
• Cialis for erectile dysfunction and benign prostatic hyperplasia.
• Forteo for osteoporosis.

COVID-19 Medications

• Bamlanivimab and etesevimab.
• Bebtelovimab.

Collaborations

The company collaborates with various organizations including:

• Incyte Corporation
• Boehringer Ingelheim Pharmaceuticals, Inc.
• AbCellera Biologics Inc.
• Junshi Biosciences
• Regor Therapeutics Group
• Lycia Therapeutics, Inc.
• Kumquat Biosciences Inc.
• Entos Pharmaceuticals Inc.
• Foghorn Therapeutics Inc.